跳至主要内容
临床试验/ACTRN12606000067572
ACTRN12606000067572已完成不适用

Does a polypill improve cardiovascular guideline implementation in primary care in those at high risk of cardiovascular disease

Health Research Council of New Zealand0 个研究点目标入组 600 人开始时间: 2006年2月16日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
600

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • 1. Adults with 5-year cardiovascular risk of at least 15%2. The General Practitioner has the opinion that all the medications in at least one of the polypills are indicated3. The General Practitioner has uncertainty whether therapy is best provided as a polypill or with usual care4. The participant is able to give informed consent.

排除标准

  • 1. Contraindication to any of the components of the relevant combination capsule 2. Confirmed clinical diagnosis of congestive heart failure (CHF) or currently treated CHF 3. Documented haemorrhagic stroke 4. Active stomach or duodenal ulcer 5. On warfarin 6. The General Practitioner has the opinion that changing a patient's cardiovascular medications would put the patient at risk 7. Known situation where medication regimen might be altered for a significant length of time 8. Unlikely to complete the trial or the trial procedures.

研究者

相似试验